资讯库
更紧凑的生命科学资讯库。
先搜索，再按来源或主题继续收窄。
雅虎财经：与主要药企合作后股价飙升14%，赛默飞世尔股票是否仍具投资价值？
Are Thermo Fisher Shares a Fair Deal After Key Pharma Partnerships and 14% Price Surge? Yahoo Finance
2025年11月25日其他值得关注的新闻
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Actimed, Aptose, Austrianova, Avant, Celltrion,...
2025年11月25日监管措施
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Celltrion, Hen...
DelveInsight估计：2024年IgG4相关疾病市场规模达1.7亿美元 | 涉及Zenas BioPharma、Horizon Therapeutics、赛诺菲、罗氏、艾伯维、吉利德科学、武田等公司 - Barchart.com报道
IgG4-related disease Market Size was USD 170 million in 2024, estimates DelveInsight | Zenas BioPharma, Horizon Therapeutics, Sanofi, Roche, AbbVie, Gilead Sciences, Ta...